GC
EBS icon

Gould Capital’s Emergent Biosolutions EBS Stock Holding History

Gould Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$830 Hold
100
– – ﹤0.01% 195
2025
Q4 		$1.24K Hold
100
– – ﹤0.01% 183
2025
Q3 		$882 Hold
100
– – ﹤0.01% 205
2025
Q2 		$638 Hold
100
– – ﹤0.01% 206
2025
Q1 		$486 Hold
100
– – ﹤0.01% 205
2024
Q4 		$956 Hold
100
– – ﹤0.01% 197
2024
Q3 		$835 Hold
100
– – ﹤0.01% 202
2024
Q2 		$682 Hold
100
– – ﹤0.01% 206
2024
Q1 		$253 Hold
100
– – ﹤0.01% 189
2023
Q4 		$240 Hold
100
– – ﹤0.01% 192
2023
Q3 		$316 Hold
100
– – ﹤0.01% 192
2023
Q2 		$735 Buy
+100
New +$927 ﹤0.01% 186

Other funds holding EBS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM